Madecassoside
 | This article or section is undergoing significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template. If you are actively editing this article or section, you can replace this template with {{in use|5 minutes}}.
This article was last edited by Lamro (talk | contribs) 3 months ago. (Update timer) |
 | |
| Names | |
|---|---|
| Other names
Redermic, Asiaticoside A
| |
| Identifiers | |
| ChEBI | |
| ECHA InfoCard | 100.047.327 |
| EC Number |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| Properties | |
| C48H78O20 | |
| Molar mass | 975.132 g·mol−1 |
| Appearance | white crystals |
| Density | 1.47 g/cm3 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Madecassoside is a pentacyclic triterpenoid extracted from the plant Centella asiatica.[1]
Uses
Scientific studies have confirmed the anti-inflammatory activity of this substance, already known in traditional medicine through the use of the plant from which it is extracted.[2][3]
References
- ^ James, Jacinda T.; Dubery, Ian A. (9 October 2009). "Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban". Molecules. 14 (10): 3922–3941. doi:10.3390/molecules14103922. Retrieved 21 July 2025.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Pullaiah, T. (15 December 2021). An Introduction to Nephroprotective Plants. Bentham Science Publishers. p. 346. ISBN 978-981-5036-61-9. Retrieved 21 July 2025.
- ^ Barkat, Md Abul (29 December 2021). Nanotechnology Driven Herbal Medicine for Burns: From Concept to Application. Bentham Science Publishers. p. 30. ISBN 978-981-5039-60-3. Retrieved 21 July 2025.